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A number of therapeutic agents (principally hypolipidaeniic compounds) and industrial chemicals have been shown, both biochemically and ultrastructurally, to increase the number of peroxisomes in the liver of rodents, chiefly rats and mice. Other species, including man, have been less intensively studied than rodents but the information available suggests that they appear t o be less susceptible t o the production of an increase in hepatic peroxisomes by these agents (Cohen & Grasso, 1981) .
Short-term studies in rodents
A dosc-related hepatomegaly is consistently reported in toxicological studies on peroxisome proliferators (Lake et al.. 1975) . Although histologically these livers appear normal. recent studies suggest that a centrilobular loss of glycogen and periportal fatty change occur (Price. 1984) . These changes are indicative of a mild toxic effect on the liver and d o not occur at dose levels which d o not induce hepatomegaly (Reddy & Lalwani. 1983) .
Medium-and long-term studies
These 'mediumterm' changes consist o f an accumulation of a pigment which is normally regarded as a residue of lysosomal activity. Histochemically the pigment gave a reaction which fulfils the criteria of lipofuscin: it was positive by thc PAS and Schmorl's techniques and was autotluorescent (Rcddy & Lalwani. 1983) . Lipofuscin is now regarded as the polymerization product of lipid peroxidation within the cell (Hartroft & Porta. 1972) . Its appearance in long-term studies lends considerable support t o the hypothesis that generation of reactive oxygen species as well as hydrogen peroxide is taking place within the hepatocyte.
The long-term effects of peroxisome proliferators are undoubtedly the most important and have given rise t o considerable concern regarding their implications for man. All the peroxisome proliferators that have been studied so far have induced a dose-related increase in hepatocellular Vol. 13 carcinoma (Reddy & Lalwani. 1983) . The tumours are usually well differentiated and non-invasive but they metastasize readily to the lung.
The peroxisome proliferators that have been studied so far are all non-mutagenic and there is n o evidence that they are metabolized t o reactive intermediates (Cohen & Grasso, 1981) . It is thus unlikely that the cancers arise from the direct action o f the compounds themselves or their metabolites.
According t o current cancer theory, neoplasia results from a heritable change in a somatic cell which confers on the cell the ability of uncontrolled proliferation. Although the causes of many such mutagenic events are unknown there is little doubt that they niay be produced by reactive chemicals which interact with the DNA. Peroxides and hydroperoxides are known t o be mutagenic (Yamaguchi & Yamashita, 1980) . Hydrogen peroxide, a member o f this group, is known t o be mutagenic and t o have produced tumours in the duodenum of rats on prolonged administration (Steit et al., 1982; Ito etal., 1984) . Based on these considerations Reddy suggested that the probable cause of cancer is the hydrogen peroxide produced within the hepatocyte (Reddy & Lalwani, 1983) .
Despite its plausibility this hypothesis is as yet unsupported by evidence of DNA damage in the liver of rats given high doses of one of this group of compounds. Furthermore, there is n o adequate proof that the natural defences within the cell, for example glutathione levels, are depleted t o an extent that would lead one t o suspect that they are inadequate for affording an adequate degree of protection t o the cell organelles including the nucleus.
Until more evidence of this sort is accumulated it might be of some merit to look for an explanation, at the cellular level, for the development of the hepatic tumours at the cellular level. Experiments with di-(2-ethylhexyl)phthalate and fenofibrate have shown that the liver growth which occurs early in the experiment is the result of hepatocellular hyperplasia (Price, 1984) . The same mechanism accounts for liver growth by a number of other chemical agents such as phenobarbitone, chlorinated hydrocarbons and a series of other compounds which differ markedly in chemical structure but which also produce hepatocellular carcinoma BIOCHEMICAL SOCIETY TRANSACTIONS (Schulte-Hermann, 1984) . Careful studies of the liver cell changes produced by some of these compounds over several months reveal that there is a gradual and persistent increase in nuclear DNA leading t o mononuclear. or less commonly, binuclear. polyploid hepatocytes as well as an increase in mitotic activity (Schulte-Hermann, 1984) . The increase in DNA which occurs in polyploid cells is interpreted by many biologists as endonuclear reduplication and is regarded as the counterpart of mitotic activity (Brodsky & Uryvaeva, 1977) . According t o this view chemically induced liver enlargement involves a persistent hyperplasia of the hepatocytes.
If this is the case, then the hyperplastic process could account for the developnient of tumours since persistent hyperplasia in other tissues, notably the subcutaneous tissue and the urothelium, leads to the formation of malignant tumours (Grasso, 1976) .
Significance for man
Knowledge of the effects of peroxisome proliferators in man is derived from the administration of therapeutic doses of hypolipidaemic agents. On a mg/kg basis these doses are usually equivalent to the lower dose-range administered t o rodents in toxicity studies. At this dose-range, many hypolipidaemic agents induce a marginal increase in peroxisonies compared with higher levels at which tumours of the liver appear. So far there is little convincing evidence that, a t therapeutic doses. the hypolipidaemic agents induce an increase in peroxisomes in human liver (Hanefeld et al., 1983) . Furthermore, n o lipofuscin granules have been reported (Cohen & Grasso. 198 1) .
These results suggest that any biochemical disturbances produced in man by peroxisome proliferators are unlikely t o produce tumours of the liver.
